Improving community health-care systems' early detection of cognitive decline and dementia

被引:4
作者
Khachaturian, Ara S. [1 ]
机构
[1] Campaign Prevent Alzheimers Dis, Rockville, MD 20850 USA
关键词
ALZHEIMERS-DISEASE; PREVENTION; IMPAIRMENT; REGISTRY; STRATEGY; ROADMAP; PLAN;
D O I
10.1002/alz.12837
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Preliminary estimates suggest that current global health-care systems lack the resource capacity to provide persons with dementia timely access to diagnosis, treatment, and care. There is an increasing need to improve timely identification of individuals who will likely progress to Alzheimer's disease (AD) dementia particularly among under-represented, underserved, and vulnerable populations. The rapidly evolving area of bioinformatics of health system data and the emergence of fluid-based biomarkers for pre-symptomatic AD may provide an innovative strategic option for health system planners. A think-tank style meeting entitled "The Campaign to Prevent Alzheimer's Disease Work Group on Community-Based Detection and Assessment of Cognitive Decline" developed recommendations to guide future sustainability activities, public policy campaigns, and implementation pilots. The group identified and explored different pathways of community-based detection using electronic health records, from different international health-care systems, to detect and surveil individuals with early possible cognitive impairment.
引用
收藏
页码:2375 / 2381
页数:7
相关论文
共 32 条
  • [1] Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease
    Aisen, Paul
    Albert, Marilyn
    Carrillo, Maria
    Diaz-Brinton, Roberta
    Davies, Peter
    DeKosky, Steven
    Fillit, Howard
    Goate, Alison
    Hodes, Richard
    Khachaturian, Ara S.
    Khachaturian, Zaven S.
    Jack, Clifford R.
    Mucke, Lennart
    Nixon, Ralph A.
    Paul, Steve
    Petersen, Ronald C.
    Potter, William
    Reiman, Eric
    Schenk, Dale
    Thies, William
    Gallagher-Thompson, Dolores
    Yaffe, Kristine
    [J]. ALZHEIMERS & DEMENTIA, 2012, 8 (04) : 357 - 371
  • [2] 2018 Alzheimer's disease facts and figures
    不详
    [J]. ALZHEIMERS & DEMENTIA, 2018, 14 (03) : 367 - 425
  • [5] [Anonymous], 2013, EM TRENDS BIOM HLTH
  • [6] "Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?
    Breitner, John C. S.
    Dodge, Hiroko H.
    Khachaturian, Zaven S.
    Khachaturian, Ara S.
    [J]. ALZHEIMERS & DEMENTIA, 2022, 18 (03) : 389 - 392
  • [7] Operationalizing the Diagnostic Criteria for Mild Cognitive Impairment: The Salience of Objective Measures in Predicting Incident Dementia
    Brodaty, Henry
    Aerts, Liesbeth
    Crawford, John D.
    Heffernan, Megan
    Kochan, Nicole A.
    Reppermund, Simone
    Kang, Kristan
    Maston, Kate
    Draper, Brian
    Trollor, Julian N.
    Sachdev, Perminder S.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (05) : 485 - 497
  • [8] Behavioral symptoms related to cognitive impairment
    Dillon, Carol
    Serrano, Cecilia M.
    Castro, Diego
    Leguizamon, Patricio Perez
    Heisecke, Silvina L.
    Taragano, Fernando E.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1443 - 1455
  • [9] Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review
    Graham, Sarah A.
    Lee, Ellen E.
    Jeste, Dilip, V
    Van Patten, Ryan
    Twamley, Elizabeth W.
    Nebeker, Camille
    Yamada, Yasunori
    Kim, Ho-Cheol
    Depp, Colin A.
    [J]. PSYCHIATRY RESEARCH, 2020, 284
  • [10] The ethics of disease-modifying drugs targeting Alzheimer disease: response to our commentators
    Gustavsson, Erik
    Raaschou, Pauline
    Larfars, Gerd
    Sandman, Lars
    Juth, Niklas
    [J]. JOURNAL OF MEDICAL ETHICS, 2022, 48 (03) : 193 - 193